Regarding “Improved outcomes are associated with multilevel endovascular intervention involving the tibial vessels compared with isolated tibial intervention”  by Canaud, Ludovic & Alric, Pierre
JOURNAL OF VASCULAR SURGERY
August 2009476 Letters to the editorregistry data in the Discussion section of the article. As a major
point of clarification, this is not an observational cohort study but
rather a real-world patient registry.
With respect to the first issue of complete and unbiased
follow-up, Drs Meier and Hayward are correct in identifying
systematic differences, noting that the Center for Medicare and
Medicaid Services mandates in-hospital results only for carotid
artery stenting (CAS) and not carotid endarterectomy (CEA).
However, the Society for Vascular Surgery (SVS) Vascular Registry
(VR) was designed with this knowledge beforehand, and as a
condition of participation in VR, some centers agreed to enter
both interventions as well as follow-up.
The goal of the article was to report the results of the entire
VR, since it is the first large-scale registry that has available data on
the current practice application of CAS and CEA. Although the VR
does not have predefined visit intervals, it does rely on each
facility’s standards of care to capture the real-world experience,
including follow-up. As noted in the article, in-hospital and 30-day
comparisons were both reported. The in-hospital results were
reported on 100% of patients; and even in this comparison, the
results have shown, in this registry, the superiority of CEA.
With respect to rigorous controls for confounders, there are
several aspects to discuss. It is true that a great deal of selection bias
can be introduced in a real-world setting in which physicians are
allowed to choose which procedure better suits the best interest of
the patient. By definition, patients who receive CAS are going to be
of a higher risk than patients who receive CEA. Thus, because this
is a current clinical practice (real-world experience) registry, diver-
sity in the patient population is expected and cannot have “rigor-
ous control for confounders.” In an effort to adjust for these
confounders, the authors performed logistic regression using back-
wards elimination, as described in the manuscript. It had also been
suggested in another Letter to the Editor that propensity score
matching be used,1 for which the authors had responded that even
with using propensity matching, still CAS patients had worse
30-day outcomes than CEA patients.2
Drs Meier and Hayward also contend that the VR results are in
conflict with several randomized controlled trials (RCTs) compar-
ing CAS and CEA. Although some RCT results conflict with the
VR results, other RCTs, such as Endarterectomy versus Stenting in
Patients with Symptomatic Severe Carotid Stenosis (EVA-3S),3 are
not in disagreement. Rather, 30-day results of EVA-3S show worse
outcomes of CAS (9.6%) vs CEA (3.9%) than that reported from
VR, as do the 4-year results of EVA-3S.4 We would like to reiterate
the conclusion at the end of the article, that “The debate about the
interpretation of the results of this study as well as results of other
CAS studies will continue until randomized trials such as Interna-
tional Carotid Stenting Study (ICSS) in Europe and CREST in
North America are reported.”5
Anton N. Sidawy, MD, MPH
Rebecca J. Shackelton, ScM
Flora S. Siami, MPH
and the SVS Outcomes Committee
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Regarding “Improved outcomes are associated with
multilevel endovascular intervention involving the
tibial vessels compared with isolated tibial
intervention”
It was with great interest that we read the article by Sadek et
al.1 They concluded that patients who undergo multilevel inter-
vention involving the tibial vessels exhibit improved secondary
patency compared with those who undergo intervention for lesions
isolated to the tibial vessels. We wholeheartedly agree with their
opinion as well as their recommendation.
The authors reported that a comparison between single-level
intervention and multilevel intervention involving the infrapopli-
teal vasculature has never been performed. Actually, we first de-
scribed the importance of multilevel endovascular intervention
involving the infrapopliteal vasculature.2 Furthermore, we re-
ported the fact that more than one tibial artery vessel being treated
in the same setting could be an explanation for a better outcome or
improved results.
The aim for performing multilevel endovascular intervention
is to improve the runoff and, therefore, decrease the risk of
restenosis related to the fact that poor runoff was reported as a
variable predicting restenosis. We definitely need to be more
aggressive and treat all reachable lesions to improve clinical out-
comes of endovascular procedures. Multilevel lesions should not
be considered a limitation for an endovascular approach, and on
the contrary, as reported in this article and in our experience,
should prompt us to consider endovascular as a first-line procedure
in patients with critical limb ischemia.
Ludovic Canaud, MD
Pierre Alric, MD, PhD
Department of Vascular and Thoracic Surgery
Hospital A de Villeneuve
Montpellier, France
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Regarding “Open-cell versus closed-cell stent design
differences in blood flow velocities after carotid
stenting”
Although several studies have suggested that stent placement
in the carotid artery alters its biomechanical properties, leading to
an increase in Duplex Ultrasound (DUS) velocities in the absence
of residual stenosis, many uncertainties remain about the general-
izability of these single-center results with small sample sizes.1
Recently, Pierce et al described disproportionately elevated veloc-
ities for closed cell design when comparing different types of
stents.2 Surprisingly, the authors concluded that their results were
